CLOV: Clover Health Investments Corp Financial Statements
Balance sheet, income statement, and cash flow statements for Clover Health Investments Corp (CLOV).
$1.58B Market Cap.
CLOV Market Cap. (MRY)
CLOV Shares Outstanding (MRY)
CLOV Assets (MRY)
Total Assets
$580.74M
Total Liabilities
$239.60M
Total Investments
$243.07M
CLOV Income (MRY)
Revenue
$1.37B
Net Income
-$43.01M
Operating Expense
$410.55M
CLOV Cash Flow (MRY)
CF Operations
$34.84M
CF Investing
$565.00K
CF Financing
-$17.36M
CLOV Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $580,742,000 (1.76%) | $570,671,000 (-29.43%) | $808,620,000 (-14.95%) | $950,804,000 (255.77%) |
Assets Current | $343,124,000 (-19.83%) | $427,970,000 (-31.52%) | $624,997,000 (-16.95%) | $752,546,000 (296.53%) |
Assets Non-Current | $237,618,000 (66.51%) | $142,701,000 (-22.29%) | $183,623,000 (-7.38%) | $198,258,000 (155.92%) |
Goodwill & Intangible Assets | $2,990,000 (0.00%) | $2,990,000 (-85.05%) | $20,000,000 (372.48%) | $4,233,000 (0.00%) |
Shareholders Equity | $341,143,000 (19.12%) | $286,394,000 (-19.75%) | $356,887,000 (-33.34%) | $535,414,000 (186.76%) |
Property Plant & Equipment Net | $5,307,000 (4.43%) | $5,082,000 (-48.03%) | $9,778,000 (27.75%) | $7,654,000 (-23.15%) |
Cash & Equivalents | $194,543,000 (67.12%) | $116,407,000 (12.16%) | $103,791,000 (-65.40%) | $299,968,000 (224.82%) |
Accumulated Other Comprehensive Income | -$1,584,000 (33.16%) | -$2,370,000 (74.72%) | -$9,374,000 (-384.69%) | -$1,934,000 (-19440.00%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $243,074,000 (0.93%) | $240,823,000 (-34.75%) | $369,080,000 (-24.87%) | $491,226,000 (736.06%) |
Investments Current | $27,012,000 (-77.46%) | $119,822,000 (-48.12%) | $230,970,000 (-26.74%) | $315,287,000 (7126.38%) |
Investments Non-Current | $216,062,000 (78.56%) | $121,001,000 (-12.39%) | $138,110,000 (-21.50%) | $175,939,000 (223.46%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $51,539,000 (-19.68%) | $64,164,000 (-56.40%) | $147,158,000 (97.54%) | $74,494,000 (48.65%) |
Trade & Non-Trade Payables | $190,960,000 (9.57%) | $174,284,000 (-46.23%) | $324,149,000 (56.73%) | $206,826,000 (53.61%) |
Accumulated Retained Earnings (Deficit) | -$2,202,803,000 (-1.99%) | -$2,159,794,000 (-10.96%) | -$1,946,433,000 (-20.39%) | -$1,616,738,000 (-57.12%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $0 (0%) | $0 (0%) | $5,860,000 (-78.94%) | $27,827,000 (-79.89%) |
Debt Current | $0 (0%) | $0 (0%) | $1,827,000 (-40.27%) | $3,059,000 (-88.05%) |
Debt Non-Current | $0 (0%) | $0 (0%) | $4,033,000 (-83.72%) | $24,768,000 (-78.04%) |
Total Liabilities | $239,599,000 (-15.72%) | $284,277,000 (-37.07%) | $451,733,000 (9.78%) | $411,487,000 (-4.90%) |
Liabilities Current | $213,516,000 (-18.23%) | $261,115,000 (-39.49%) | $431,507,000 (15.80%) | $372,624,000 (126.89%) |
Liabilities Non-Current | $26,083,000 (12.61%) | $23,162,000 (14.52%) | $20,226,000 (-47.96%) | $38,863,000 (-85.52%) |
CLOV Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $1,371,131,000 (8.77%) | $1,260,543,000 (14.96%) | $1,096,552,000 (-25.51%) | $1,471,996,000 (118.76%) |
Cost of Revenue | $1,006,327,000 (0.90%) | $997,351,000 (10.87%) | $899,556,000 (-45.87%) | $1,661,806,000 (190.04%) |
Selling General & Administrative Expense | $408,934,000 (-7.11%) | $440,246,000 (-8.74%) | $482,403,000 (8.22%) | $445,745,000 (132.05%) |
Research & Development Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Expenses | $410,553,000 (-12.37%) | $468,521,000 (-3.13%) | $483,660,000 (8.16%) | $447,182,000 (132.13%) |
Interest Expense | $0 (0%) | $7,000 (-99.47%) | $1,333,000 (-58.25%) | $3,193,000 (-91.13%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | -$3,257,000 (-201.37%) | $3,213,000 (-96.22%) | $84,983,000 (0%) | $0 (0%) |
Consolidated Income | -$43,009,000 (79.84%) | -$213,361,000 (37.17%) | -$339,567,000 (42.23%) | -$587,756,000 (-330.93%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$43,009,000 (79.84%) | -$213,361,000 (37.17%) | -$339,567,000 (42.23%) | -$587,756,000 (-330.93%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$43,009,000 (79.84%) | -$213,361,000 (37.17%) | -$339,567,000 (42.23%) | -$587,756,000 (-330.93%) |
Weighted Average Shares | $490,018,730 (1.63%) | $482,176,127 (1.25%) | $476,244,262 (15.34%) | $412,922,424 (365.57%) |
Weighted Average Shares Diluted | $490,018,730 (1.63%) | $482,176,127 (1.25%) | $476,244,262 (15.34%) | $412,922,424 (365.57%) |
Earning Before Interest & Taxes (EBIT) | -$43,009,000 (79.84%) | -$213,354,000 (36.92%) | -$338,234,000 (42.14%) | -$584,563,000 (-482.22%) |
Gross Profit | $364,804,000 (38.61%) | $263,192,000 (33.60%) | $196,996,000 (203.79%) | -$189,810,000 (-289.94%) |
Operating Income | -$45,749,000 (77.72%) | -$205,329,000 (28.37%) | -$286,664,000 (55.00%) | -$636,992,000 (-587.10%) |
CLOV Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | $565,000 (-99.60%) | $140,013,000 (47.18%) | $95,133,000 (121.85%) | -$435,447,000 (-416.91%) |
Net Cash Flow from Financing | -$17,361,000 (-242.43%) | -$5,070,000 (-2.18%) | -$4,962,000 (-100.54%) | $925,393,000 (15734.92%) |
Net Cash Flow from Operations | $34,845,000 (124.09%) | -$144,662,000 (29.06%) | -$203,926,000 (27.77%) | -$282,326,000 (-138.25%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $18,049,000 (285.71%) | -$9,719,000 (91.46%) | -$113,755,000 (-154.79%) | $207,620,000 (738.87%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | -$16,450,000 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $2,121,000 (-98.49%) | $140,597,000 (21.15%) | $116,050,000 (126.70%) | -$434,724,000 (-414.80%) |
Capital Expenditure | -$1,556,000 (-166.44%) | -$584,000 (86.93%) | -$4,467,000 (-517.84%) | -$723,000 (-4.33%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | -$30,925,000 (-2577.96%) |
Issuance (Purchase) of Equity Shares | -$17,361,000 (-242.43%) | -$5,070,000 (-2.18%) | -$4,962,000 (-100.52%) | $956,318,000 (120799.87%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $114,331,000 (-18.87%) | $140,931,000 (-14.23%) | $164,305,000 (0.36%) | $163,723,000 (2213.13%) |
Depreciation Amortization & Accretion | $1,331,000 (-46.95%) | $2,509,000 (111.37%) | $1,187,000 (-4.74%) | $1,246,000 (124.50%) |
CLOV Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 26.60% (27.27%) | 20.90% (16.11%) | 18.00% (239.53%) | -12.90% (-186.58%) |
Profit Margin | -3.10% (81.66%) | -16.90% (45.48%) | -31.00% (22.31%) | -39.90% (-96.55%) |
EBITDA Margin | -3.00% (82.04%) | -16.70% (45.60%) | -30.70% (22.47%) | -39.60% (-167.57%) |
Return on Average Equity (ROAE) | -13.20% (80.47%) | -67.60% (17.06%) | -81.50% (36.23%) | -127.80% (-358.70%) |
Return on Average Assets (ROAA) | -6.70% (65.99%) | -19.70% (-3.14%) | -19.10% (67.63%) | -59.00% (-54.05%) |
Return on Sales (ROS) | -3.10% (81.66%) | -16.90% (45.13%) | -30.80% (22.42%) | -39.70% (-166.44%) |
Return on Invested Capital (ROIC) | -37.40% (83.24%) | -223.10% (-26.55%) | -176.30% (-31.67%) | -133.90% (-294.99%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -35 (-1517.38%) | -2.16 (-23.38%) | -1.75 (33.05%) | -2.62 (75.94%) |
Price to Sales Ratio (P/S) | 1.13 (209.34%) | 0.36 (-9.90%) | 0.4 (-61.30%) | 1.04 (-52.76%) |
Price to Book Ratio (P/B) | 4.63 (185.44%) | 1.62 (30.20%) | 1.25 (-60.68%) | 3.17 (128.81%) |
Debt to Equity Ratio (D/E) | 0.7 (-29.31%) | 0.99 (-21.56%) | 1.27 (64.63%) | 0.77 (209.70%) |
Earnings Per Share (EPS) | -0.09 (79.55%) | -0.44 (16.98%) | -0.53 (62.68%) | -1.42 (7.79%) |
Sales Per Share (SPS) | 2.8 (7.04%) | 2.61 (13.55%) | 2.3 (-35.43%) | 3.56 (-53.01%) |
Free Cash Flow Per Share (FCFPS) | 0.07 (122.59%) | -0.3 (31.28%) | -0.44 (36.06%) | -0.69 (49.03%) |
Book Value Per Share (BVPS) | 0.7 (17.17%) | 0.59 (-20.69%) | 0.75 (-42.25%) | 1.3 (118.64%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.18 (0.17%) | 1.18 (-28.93%) | 1.66 (-27.75%) | 2.29 (-22.72%) |
Enterprise Value Over EBIT (EV/EBIT) | -30 (-2900.00%) | -1 (0%) | 0 (0%) | -3 (95.59%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -31.05 (-3747.83%) | -0.81 (-210.38%) | -0.26 (90.03%) | -2.61 (96.18%) |
Asset Turnover | 2.13 (83.12%) | 1.16 (88.17%) | 0.62 (-58.23%) | 1.48 (-21.89%) |
Current Ratio | 1.61 (-1.95%) | 1.64 (13.19%) | 1.45 (-28.32%) | 2.02 (74.74%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | $33,289,000 (122.92%) | -$145,246,000 (30.30%) | -$208,393,000 (26.38%) | -$283,049,000 (-137.48%) |
Enterprise Value (EV) | $1,294,203,463 (660.26%) | $170,231,792 (94.30%) | $87,611,714 (-94.24%) | $1,521,146,951 (-77.70%) |
Earnings Before Tax (EBT) | -$43,009,000 (79.84%) | -$213,361,000 (37.17%) | -$339,567,000 (42.23%) | -$587,756,000 (-330.93%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$41,678,000 (80.23%) | -$210,845,000 (37.44%) | -$337,047,000 (42.22%) | -$583,317,000 (-484.21%) |
Invested Capital | $169,693,000 (-10.76%) | $190,159,000 (-26.63%) | $259,182,000 (-14.12%) | $301,806,000 (108.43%) |
Working Capital | $129,608,000 (-22.32%) | $166,855,000 (-13.77%) | $193,490,000 (-49.07%) | $379,922,000 (1386.74%) |
Tangible Asset Value | $577,752,000 (1.77%) | $567,681,000 (-28.02%) | $788,620,000 (-16.69%) | $946,571,000 (259.89%) |
Market Capitalization | $1,578,493,463 (239.98%) | $464,285,792 (4.51%) | $444,248,714 (-73.79%) | $1,694,934,951 (-75.01%) |
Average Equity | $325,167,750 (3.07%) | $315,480,750 (-24.24%) | $416,400,500 (-9.47%) | $459,946,250 (266.65%) |
Average Assets | $644,933,750 (-40.59%) | $1,085,513,500 (-38.93%) | $1,777,349,750 (78.35%) | $996,530,250 (180.03%) |
Invested Capital Average | $115,053,750 (20.32%) | $95,622,750 (-50.15%) | $191,804,000 (-56.07%) | $436,572,250 (47.41%) |
Shares | 501,109,036 (2.76%) | 487,643,937 (2.03%) | 477,943,748 (4.90%) | 455,627,675 (12.66%) |